The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation

The aim of this study was to determine the utility of rapid atrial pacing immediately after transcatheter aortic valve replacement (TAVR) to predict the need for permanent pacemaker implantation (PPI). Risk stratification for patients without high-grade atrioventricular block (AVB) after TAVR is imp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Cardiovascular interventions 2020-05, Vol.13 (9), p.1046-1054
Hauptverfasser: Krishnaswamy, Amar, Sammour, Yasser, Mangieri, Antonio, Kadri, Amer, Karrthik, Antonette, Banerjee, Kinjal, Kaur, Manpreet, Giannini, Francesco, Pagliaro, Beniamino, Ancona, Marco, Pagnesi, Matteo, Laricchia, Alessandra, Weisz, Giora, Lyden, Megan, Bazarbashi, Najdat, Gad, Mohamed, Ahuja, Keerat, Mick, Stephanie, Svensson, Lars, Puri, Rishi, Reed, Grant, Rickard, John, Colombo, Antonio, Kapadia, Samir, Latib, Azeem
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of this study was to determine the utility of rapid atrial pacing immediately after transcatheter aortic valve replacement (TAVR) to predict the need for permanent pacemaker implantation (PPI). Risk stratification for patients without high-grade atrioventricular block (AVB) after TAVR is imprecise and based on anatomic considerations, electrocardiographic characteristics, and clinical suspicion. A more reliable assessment is necessary to minimize inpatient rhythm monitoring and/or reduce unnecessary PPI. Consecutive patients undergoing TAVR at 2 centers were included. After valve implantation in patients without pacemakers who did not have complete heart block or atrial fibrillation, the temporary pacemaker was withdrawn from the right ventricle and placed in the right atrium. Rapid atrial pacing was performed from 70 to 120 beats/min, and patients were assessed for the development of Wenckebach AVB. Patients were then followed for clinical outcomes, including PPI. A total of 284 patients were included. Of these, 130 (45.8%) developed Wenckebach AVB. There was a higher rate of PPI within 30 days of TAVR among the patients who developed Wenckebach AVB (13.1% vs. 1.3%; p 
ISSN:1936-8798
1876-7605
DOI:10.1016/j.jcin.2020.01.215